Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined exercise and L-arginine in hypertensive postmenopausal women
IRCT20210627051723N1Phase 3Completed
- Sponsor
- University of Tehran
- Start
- Jul 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of arginine in hypertension (HTN), sponsored by University of Tehran. Primary endpoints: Change in adropin levels, Change in VEGFR-2 levels and 1 more. Started Jul 2021; status: completed.
02
Drugs
arginine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on IRCT20210627051723N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210627051723N1.